HER2 Support Group Forums - View Single Post - Adding veliparib to chemotherapy can extend progression-free survival in patients wit

News · 02-01-2023, 01:41 AM

Results from the SWOG S1416 clinical trial show that adding veliparib to chemotherapy can significantly extend progression-free survival (PFS) times in patients with triple-negative breast cancer (TNBC) that has a "BRCA-like" phenotype.

More...

02-01-2023, 01:41 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 18,987	Adding veliparib to chemotherapy can extend progression-free survival in patients wit Results from the SWOG S1416 clinical trial show that adding veliparib to chemotherapy can significantly extend progression-free survival (PFS) times in patients with triple-negative breast cancer (TNBC) that has a "BRCA-like" phenotype. More...